<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li X</submitter><funding>Natural Science Foundation of Hubei Province</funding><funding>Doctor Foundation of Wuhan Children's Hospital</funding><funding>National Natural Science Foundation of China</funding><pagination>262</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9954168</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(2)</volume><pubmed_abstract>Epilepsy is a neurological disease and approximately 30% of patients have failed to respond to current anti-epilepsy drugs. The neuroinflammation mechanism has raised increasing concerns and been regarded as the novel treatment strategy in epilepsy, but the target molecules require further research. Pyruvate kinase isoform 2 (PKM2) is well studied in peripheral inflammation, but its role in epilepsy neuroinflammation remains unclear. We knocked down microglia PKM2 in the hippocampus using a stereotaxic adeno-associated virus (AAV) microinjection and established a pilocarpine-induced status epilepticus (PISE) model. Racine score was used to evaluate the seizure grade. Next, we used WB, Multiplex tyramide signal amplification (TSA) staining and other methods to determine neuroinflammation an</pubmed_abstract><journal>Brain sciences</journal><pubmed_title>Microglia PKM2 Mediates Neuroinflammation and Neuron Loss in Mice Epilepsy through the Astrocyte C3-Neuron C3R Signaling Pathway.</pubmed_title><pmcid>PMC9954168</pmcid><funding_grant_id>2020CFB357</funding_grant_id><funding_grant_id>2020FEBSJJ003</funding_grant_id><funding_grant_id>82003738</funding_grant_id><pubmed_authors>Peng H</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Mei M</pubmed_authors><pubmed_authors>Zhou R</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Peng J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Microglia PKM2 Mediates Neuroinflammation and Neuron Loss in Mice Epilepsy through the Astrocyte C3-Neuron C3R Signaling Pathway.</name><description>Epilepsy is a neurological disease and approximately 30% of patients have failed to respond to current anti-epilepsy drugs. The neuroinflammation mechanism has raised increasing concerns and been regarded as the novel treatment strategy in epilepsy, but the target molecules require further research. Pyruvate kinase isoform 2 (PKM2) is well studied in peripheral inflammation, but its role in epilepsy neuroinflammation remains unclear. We knocked down microglia PKM2 in the hippocampus using a stereotaxic adeno-associated virus (AAV) microinjection and established a pilocarpine-induced status epilepticus (PISE) model. Racine score was used to evaluate the seizure grade. Next, we used WB, Multiplex tyramide signal amplification (TSA) staining and other methods to determine neuroinflammation an</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-05T13:21:35.237Z</modification><creation>2024-10-15T13:24:59.898Z</creation></dates><accession>S-EPMC9954168</accession><cross_references><pubmed>36831807</pubmed><doi>10.3390/brainsci13020262</doi></cross_references></HashMap>